INFLUENCE OF POLY(DL-LACTIDE) NANOCAPSULES ON THE BILIARY CLEARANCE AND ENTEROHEPATIC CIRCULATION OF INDOMETHACIN IN THE RABBIT

被引:36
作者
FAWAZ, F
BONINI, F
GUYOT, M
LAGUENY, AM
FESSI, H
DEVISSAGUET, JP
机构
[1] UNIV PARIS 11,CTR ETUD PHARMACEUT,PHARM GALEN & BIOPHARM LAB,CNRS,URA 1218,F-92290 CHATENAY MALABRY,FRANCE
[2] FAC SCI PHARMACEUT,PHARM GALEN LAB,F-33076 BORDEAUX,FRANCE
关键词
NANOCAPSULES; POLY(DL-LACTIDE); BILIARY CLEARANCE; ENTEROHEPATIC CIRCULATION; INDOMETHACIN; RABBIT;
D O I
10.1023/A:1018924219540
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Following intravenous administration, the uptake of colloidal drug carriers by cells of the mononuclear phagocyte system, mainly the Kuppfer cells, may concentrate an encapsulated drug close to the liver parenchymal cells and facilitate its biliary excretion and enterohepatic circulation. To test this hypothesis indomethacin was administered (10 mg/kg) in four groups of 10 rabbits each by intravenous infusion at a constant rate over 2 hr, either in its free form (aqueous solution) or as nanocapsules prepared from preformed poly(DL-lactide). Unchanged drug was assayed in plasma of the two control (sham-operated) groups and in both plasma and bile of the two bile-cannulated groups. Pharmacokinetic analysis led to the conclusion that the uptake of nanocapsules by liver macrophages reduces the concentration of the drug by enhancing its total clearance. This enhancement was due to an increase in biliary clearance, as a result of parallel increases in bile concentration and biliary excretion of the drug. It was also demonstrated that nanocapsules enhance the enterohepatic circulation of indomethacin.
引用
收藏
页码:750 / 756
页数:7
相关论文
共 21 条
[1]  
Al Khouri F, 1986, INT J PHARMACEUT, V28, P125
[2]   INTERRUPTION OF THE ENTEROHEPATIC CIRCULATION OF INDOMETHACIN BY CHOLESTYRAMINE IN RABBITS [J].
ALMESHAL, MA ;
ELSAYED, YM ;
ALANGARY, AA ;
LUTFI, KM ;
GOUDA, MW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 64 (2-3) :155-160
[3]   JEJUNAL-ABSORPTION, PHARMACOLOGICAL ACTIVITY, AND PHARMACOKINETIC EVALUATION OF INDOMETHACIN-LOADED POLY(D,L-LACTIDE) AND POLY(ISOBUTYL-CYANOACRYLATE) NANOCAPSULES IN RATS [J].
AMMOURY, N ;
FESSI, H ;
DEVISSAGUET, JP ;
DUBRASQUET, M ;
BENITA, S .
PHARMACEUTICAL RESEARCH, 1991, 8 (01) :101-105
[4]   EFFECT ON CEREBRAL BLOOD-FLOW OF ORALLY-ADMINISTERED INDOMETHACIN-LOADED POLY(ISOBUTYLCYANOACRYLATE) AND POLY(DL-LACTIDE) NANOCAPSULES [J].
AMMOURY, N ;
FESSI, H ;
DEVISSAGUET, JP ;
ALLIX, M ;
PLOTKINE, M ;
BOULU, RG .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1990, 42 (08) :558-561
[5]  
AMMOURY N, 1992, IN PRESS CLIN MATER
[6]  
Andrieu V, 1989, Drug Des Deliv, V4, P295
[7]  
BECKER S, 1988, Advanced Drug Delivery Reviews, V2, P1, DOI 10.1016/0169-409X(88)90003-8
[8]   INDIRECT ASSESSMENT OF THE ENTEROHEPATIC RECIRCULATION OF PIROXICAM AND TENOXICAM [J].
BENVENISTE, C ;
STRIBERNI, R ;
DAYER, P .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 38 (06) :547-549
[9]   HEPATIC TISSUE DISTRIBUTION OF DOXORUBICIN-LOADED NANOPARTICLES AFTER IV ADMINISTRATION IN RETICULOSARCOMA M-5076 METASTASIS-BEARING MICE [J].
CHIANNILKULACHAI, N ;
AMMOURY, N ;
CAILLOU, B ;
DEVISSAGUET, JP ;
COUVREUR, P .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 (02) :122-126
[10]  
COCIGLIO M, 1992, EUR J DERUG METAB PH, V16, P275